CD45 (2B11 & PD7/26) Mouse
CD45 (2B11 & PD7/26) Mouse
| Application | IHC |
| Clone | 2B11 & PD7/26 |
| Conjugué | Unconjugated |
| Conseil | |
| Couleur | |
| Hôte | Mouse |
| Immunogène | PD7.26.16: human peripheral blood lymphocytes maintained in T cell growth factor and 2B11: isolated neoplastic cells from T cell lymphoma |
| Isotype | IgG1 kappa |
| Localisation | Membranous |
| Pathologie | Hodgkin's and NHD Lymphoma, Leukemia, Histiocytic, Undifferentiated Tumor |
| Predicted reactivity | |
| Purification | |
| Réactivité | Human |
| Spécificité | |
| Taille | |
| Tissus controles | Tonsil, Lymph Node, Thymus, Spleen |
Prêt à l'emploi
| Conditionnement | Référence | Fournisseur | Certification | Dilution | TDS | Quantité |
|---|---|---|---|---|---|---|
| 16 ml | BMS046 |
|
IVD/CE |
|
||
| 3 ml | BSB5246 |
|
IVD/CE | RTU |
|
|
| 15 ml | BSB5248 |
|
IVD/CE | RTU |
|
|
| 15 ml | 2-CD178-16 |
|
RUO | RTU | ||
| 7 ml | 2-CD178-13 |
|
RUO | RTU | ||
| 3 ml | 2-CD178-10 |
|
RUO | RTU | ||
| 7 ml | BSB5247 |
|
IVD/CE | RTU |
|
|
| 7 ml | MAD-002066QD-7 |
|
IVD/CE | RTU |
|
|
| 3 ml | MAD-002066QD-3 |
|
IVD/CE | RTU |
|
|
| 12 ml | MAD-002066QD-12 |
|
IVD/CE | RTU |
|
Concentré
| Conditionnement | Référence | Fournisseur | Certification | Dilution | TDS | Quantité |
|---|---|---|---|---|---|---|
| 1 ml | 1-CD178-07 |
|
RUO | |||
| 0,5 ml | BSB5250 |
|
IVD/CE | 1/250 - 1/1000 |
|
|
| 0,1 ml | 1-CD178-02 |
|
RUO | |||
| 0,5 ml | 1-CD178-05 |
|
RUO | |||
| 0,1 ml | BSB5249 |
|
IVD/CE | 1/250 - 1/1000 |
|
|
| 1 ml | BSB5251 |
|
IVD/CE | 1/250 - 1/1000 |
|
|
| 1 ml | MAD-002066Q |
|
IVD/CE |
|
Control Slides
| Conditionnement | Référence | Fournisseur | Certification | Dilution | TDS | Quantité |
|---|---|---|---|---|---|---|
| 5 slides | BSB5252 |
|
IVD/CE |
|
||
| 5 slides | BSB9095-CS |
|
IVD/CE |
|